United States · Series A startup

Who invested in Aggredyne

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 15 Nov 2026

$3.0Mraised across 1 round since 2012, from 1 source

Latest round
Series A, $3.0MApr 2012
Investors
0
See who backed them

The rounds

  1. Apr 2012
    Series A$3.0M

    No investor was named in the report.

    Reported by freshnews.comSEC filing: $2.9M sold, first sale Mar 2012

Funding filed with regulators

Aggredyne filed one raise, $2.9M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Mar 2012$2.9M48 investorsequityof $3.0M offeredSEC Form D

Founders and team

From the SEC filings it signed: 2 on the team.

  • Edward R TeitelExecutive Officer, Directori
  • Robert C HuxExecutive Officer, Directori

Quick answers about Aggredyne

How much has Aggredyne raised?

Aggredyne has raised $3.0M across 1 round since 2012.

When did Aggredyne last raise?

Aggredyne's most recent round was a Series A of $3.0M in Apr 2012.

What was Aggredyne's biggest round?

Its most recent round, $3.0M in Apr 2012, is also its largest on record.

What stage is Aggredyne at?

Aggredyne's latest named round is a Series A, in Apr 2012.

Where is Aggredyne based?

Aggredyne is based in the United States.

Companies like Aggredyne

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.